BioCentury
ARTICLE | Financial News

Syndexa completes venture financing

January 16, 2012 8:00 AM UTC

Syndexa Pharmaceuticals Corp., Cambridge, Mass. Business: Endocrine/Metabolic, Cardiovascular Date completed: 1/5/12 Type: Venture financing Raised: $8.5 million Investor: MP Healthcare Venture Manage...